As per the latest report by IMARC Group, titled “UAE In-Vitro Diagnostics Devices Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,” the UAE in-vitro diagnostics devices market size reached US$ 341 Million in 2019. In-vitro diagnostics (IVDs) are non-invasive tests of biological samples. These tests are completed with the help of IVD devices on samples, such as blood, tissue or urine, to diagnose infections or medical conditions, prevent diseases and monitor drug therapies. IVD devices play a vital role in diagnosing and detecting numerous diseases in the human body. At present, there is a rise in the demand for these devices in the United Arab Emirates, owing to the growing population and increasing exemption of tariffs on the imports of medical devices in the country.
UAE In-Vitro Diagnostic Devices Market Trends:
On account of subdued economic performance, fall in the oil prices and declining real estate prices in 2017, the non-oil sectors began to expand in the UAE. Along with this, the growing trend of self-care and the increasing prevalence of lifestyle diseases, such as obesity and diabetes, supported by the relatively high-income levels, have escalated the demand for superior healthcare facilities in the UAE. This, in turn, is strengthening the in-vitro diagnostic devices market. Additionally, there is a rise in the number of initiatives undertaken by healthcare authorities that emphasize preventive care via regular checkups. This is boosting the overall sales of in-vitro diagnostics devices in the country. Furthermore, the UAE Government has been focusing on building a world-class healthcare infrastructure and has been liberalizing policies to attract foreign investments. The introduction of advanced in-vitro diagnosis technologies, including next-generation sequencing, molecular diagnostics, polymerase chain reaction (PCR) and genetic testing, is further driving the market growth. Other factors that are anticipated to catalyze the demand for these devices are affordable healthcare facilities and increasing medical tourism. Looking forward, the market value is projected to reach US$ 594 Million by 2025, expanding at a CAGR of 9.7% during the forecast period (2020-2025).
- Based on the end user, hospital-based centers account for the majority of the total market share. Other segments include diagnostics chains and standalone centers.
- On the basis of the application, the market has been classified into infectious diseases, diabetes, blood test, nephrology, cardiology, oncology, autoimmune diseases and others.
- The competitive landscape of the market has been examined, along with detailed profiles of the major players operating in the industry.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Phone No: (D) +91 120 433 0800 | www.imarcgroup.com
Americas :- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331